Cardiac hypertrophy and hypertension

Current Opinion in Nephrology and Hypertension

Volumn 7, Issue 2, 1998, Pages 211-216

  Agabiti Rosei, Enrico ^a   Muiesan, Maria Lorenza ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; PLACEBO; RAMIPRIL;

AGING; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART PROTECTION; HUMAN; KIDNEY DISEASE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

AGING; ANTIHYPERTENSIVE AGENTS; CARDIOMEGALY; HUMANS; HYPERTENSION; PROGNOSIS;

EID: 0031882722     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-199803000-00011     Document Type: Article

References (46)

1. Kannel WB, Gordon T, Offut T. Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence and mortality in the Framingham study. Ann Intern Med 1969; 71:89-95.
2. Levy D. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322:1561-1566.
3. Casale PN, Devereux RB, Milner M, Zullo G, Harshfield G, Pickering T, Laragh J. Value of echocardiographic measurements of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 105:173-178.
4. Devereux RB, Agabiti-Rosei E, Dahlof B, Gosse P, Hahn RT, Okin PM, • Roman MJ. Regression of LVH as a surrogate end-point for morbid events in hypertension treatment trials. J Hypertens 1996; 14 (suppl 2):s95-s102. This article contains a complete review of the results obtained in LVH regression studies and an update of ongoing studies.
5. Levy D, Salomon M, D'Agostino R, Belanger A, Kannel WB. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation 1994; 90:1786-1793.
6. Koren MJ, Savage DD, Casale PN, Laragh JH, Devereux RB. Changes in left ventricular mass predict risk in essential hypertension [abstract]. Circulation 1990; 82 (suppl III):III29.
7. Yurenev A, Dyakonova HG, Novikov I, Vitols A, Pahl L, Haynemann G, et al. Management of essential hypertension patients with different degrees of left ventricular hypertrophy. Multicenter trial. Am J Hypertens 1992; 5 (suppl):182s-189s.
8. Muiesan ML, Salvetti M, Rizzoni D, Castellano M, Donato F, Agabiti-Rosei E. Association of change in LV mass with prognosis during long-term antihypertensive treatment. J Hypertens 1995; 13:1091-1105.
9. Porcellati C, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Verdecchia P. Prognostic value of serial changes in left ventricular mass in essential hypertension [abstract]. J Hypertens 1997; 15 (suppl 4):s99.
10. Dannemberg AL, Levy D, Garrison J. Impact of age on echocardiographic left ventricular mass in a healthy population (the Framingham Study). Am J Cardiol 1989; 64:1066-1068.
11. Gardin JM, Siscovick D, Anton-Culver H, Smith VE, Klopfestein S, Bommer W, et al. Sex, age and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly. The Cardiovascular Health Study (CHS). Circulation 1995; 91:1739-1748.
12. Gardin JM, Arnold A, Gottdiener JS, Wong ND, Fried LP, Klopfenstein HS, et al. LV mass in the elderly. The Cardiovascular Health Study. Hypertension 1997; 29:1095-1103.
13. Devereux RB, De Simone G, Ganau A, Roman MJ. Left ventricular hypertrophy and geometric remodelling in hypertension: stimuli, functional consequences and prognostic implications. J Hypertens 1994; 12 (suppl 10):s117-s127.
14. Ganau A, Saba P, Roman MJ, De Simone G, Realdi G, Devereux RB. Ageing induces left ventricular concentric remodelling in normotensive subjects. J Hypertens 1995; 13:1818-1822.
15. Sumimoto T, Mukai M, Murakami E, KokubuT, Lin M, Shigematsu Y, et al. Effect of age on left ventricular geometric patterns in hypertensive patients. J Hypertens 1995; 13:1813-1818.
16. Andren B, Lind L, Hedenstiema G, Lithell H. Left ventricular hypertrophy and geometry in a population sample of elderly males. Eur Heart J 1996; 17:1800-1807.
17. Heesen WF, Beltman FW, May J, Smit A, de Graeff P, Havinga T, et al. High prevalence of concentric remodeling in elderly individuals with isolated systolic hypertension from a population survey. Hypertension 1997; 29:539-543.
18. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimai plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986; 74:1399-1406.
19. Kronmal RA, Smith VE, O'Leary DH, Polak JF, Gardin JM, Manolio TA, et al. Carotid artery measures are strongly associated with left ventricular mass in older adults (a report from the Cardiovascular Health Study). Am J Cardiol 1996; 77:628-633.
20. Roman M, Saba PS, Pini R, Spitzer M, Pickering T, Rosen S, et al. Parallel adaptation of carotid arteries and left ventricle in hypertension. Circulation 1992; 86:1909-1918.
21. Hughes AD, Sinclair AM, Geroulakos G, Mayet J, Shahi M, Thom S, et al. Structural changes in the heart and carotid arteries associated with hypertension in humans. J Human Hypertens 1993; 3:395-397.
22. Muiesan ML, Pasini GF, Salvetti M, Calebich S, Zulli R, Castellano M, et al. Cardiac and vascular structural changes: prevalence and relation to ambulatory blood pressure in a middle aged general population in northern Italy: the Vobamo Study. Hypertension 1996; 27:1046-1053.
23. Cuspidi C, Marabini M, Lonati L, Sampieri L, Comerio G, Pelizzoli S, et al. Cardiac and carotid structure in patients with established hypertension and white coat hypertension. J Hypertens 1995; 13:1707-1711.
24. Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB. Association of carotid atherosclerotic and left ventricular hypertrophy. J Am Coll Cardiol 1995; 25:83-90.
25. Aronow WS, Kronzon I, Schoenfeld RM. Left ventricular hypertrophy is more prevalent in patients with systemic hypertension with extracranial carotid disease than in patients without extracranial carotid disease. Am J Cardiol 1995; 76:192-193.
26. Salonen JT, Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation 1993; 87 (suppl II):II56-II65.
27. Okin PM, Roman MJ, Devereux RB, Kligfield PK. Association of carotid atherosclerosis with electrocardiographic myocardial ischemia and left ventricular hypertrophy. Hypertension 1996; 28:3-7.
28. O'Leary DH, Polak F, Kronmal R, Savage P, Borhani N, Kittner SJ, et al. for the Cardiovascular Health Study Collaborative Research Group. Thickening of the carotid wall. A marker for atherosclerosis in the elderly? Stroke 1996; 27:224-231.
29. Salonen R, Seppanen K, Rauramaa R, Salonen JT. Progression of carotid atherosclerosis and its determinants: a population based ultrasonographic study. Atherosclerosis 1990; 81:33-40.
30. Rizzoni D, Porteri E, Castellano M, Bettoni G, Muiesan ML, Muiesan P, • et al. Vascular hypertrophy and remodeling in secondary hypertension. Hypertension 1996; 28:785-790. In this study the structural changes in small resistance arteries in patients with secondary hypertension are compared.
31. Cuspidi C, Lonati L, Sampieri L, Pelizzola S, Pontiggia G, Leonetti G, Zanchetti A. Left ventricular concentric remodelling and carotid structural changes in essential hypertension. J Hypertens 1996; 14:1441-1446.
32. Pierdomenico S, Lapenna D, Guglielmi MD, Porreca E, Antidormi T, Cuccurullo F, Mezzetti A. Vascular changes in hypertensive patients with different left ventricular geometry. J Hypertens 1995; 13:1701-1706.
33. Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB. Relation of arterial structure and function to left ventricular geometric patterns in hypertensive adults. J Am Coll Cardiol 1996; 28:751-756.
34. Tarazi RC, Sen S, Fouad FM, Wicker P. Regression of myocardial hypertrophy: conditions and sequelae of reversal in hypertensive heart disease. In: Perspectives in cardiovascular research, Vol. 7. Myocardial hypertrophy and failure. Alpert NR (editor). New York, NY: Raven Press; 1983. pp. 637-652.
35. Schmieder AM. Reversal of left ventricular hypertrophy in essential hyper• tension: a meta-analysis of randomized double blind studies. JAMA 1996; 275:1507-1513. A meta-analysis of studies on LVH regression, conducted with a randomized, double-blind design, gives evidence that ACE inhibitors and calcium antagonists are more effective in inducing LVH reduction compared with other classes of drugs.
36. Cruickshank JM, Lewis J, Moore V, Dodd A. Reversibility of left ventricular hypertrophy by differing types of antihypertensive therapy. J Human Hypertens 1992; 6:85-90.
37. Dahlöf B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am J Hypertens 1992; 5:95-110.
38. Neaton JD, Grimm RH, Prineas RJ, Stamler J, Grandits GA, Emler P, et al. on behalf of the Treatment of Mild Hypertension Study Research Group. Treatment of Mild Hypertension Study. Final results. JAMA 1993; 270:713-724.
39. Agabrti-Rosei E, Ambrosioni E, DalPalu' C, Muiesan ML, Zanchetti A on behalf of the RACE Study group. Ace-inhibitor ramipril is more effective than β-blocker atenolol in reducing left ventricular mass in hypertension. Results of the RACE (ramipril cardioprotective evaluation) study. J Hypertens 1995; 13:1325-1335.
40. Gottdiener JS, Reda DJ, Massie BM, Materson BJ, Williams DW, • Anderson RJ for the VA Cooperative Study Group on Antihypertensive Agents. Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension. Comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Circulation 1997; 95:2007-2014. This study compares the effect of monotherapy with different antihypertensive drugs on LVM reduction.
41. Shimuzu G, Hirota Y, Kita Y, Kawamura K, Saito T, Gaasch WH. Lett ventricular midwall mechanics in systemic arterial hypertension. Myocardial function is depressed in pressure-overload hypertrophy. Circulation 1991; 83:1676-1684.
42. de Simone G, Devereux RB, Roman MJ, Ganau A, Saba PS, Aiderman MH, Laragh JH. Assessment of left ventricular function by midwall fractional shortening-end systolic stress relation in human hypertension. J Am Coll Cardiol 1994; 23:1444-1451.
43. Aurigemma GP, Silver HK, Priest MA, Gaasch WH. Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy. J Am Coll Cardiol 1995; 26:195-202.
44. de Simone G, Devereux RB, Koren MJ, Mensah GA, Casale PN, Laragh JH. Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension. Circulation 1996; 93:259-265.
45. Muiesan ML, Salvetti M, Rizzoni D, Castellano M, Monteduro C, Agabiti• Rosei E. Persistence of left ventricular hypertrophy is a stronger indicator of cardiovascular events than baseline LV mass or systolic performance. A ten years follow-up. J Hypertens 1996; 14 (suppl 5):s43-s49. This study evaluated the prognostic significance of a depressed left ventricular systolic perfomance at the midwall and of changes of LVM during the follow-up period in hypertensive patients.
46. Levin A, Singer J, Thompson CR, Ross H, Lewis M. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis 1996; 27:347-354.